Q2 2025 FMC Corp Earnings Call Transcript
Key Points
- FMC Corp (FMC) achieved second quarter results at the higher end of expectations, with EBITDA and EPS slightly exceeding guidance.
- The company reported a 6% volume growth in sales, indicating strong demand for its products.
- FMC Corp (FMC) has successfully normalized product levels in distribution channels, setting a solid foundation for future growth.
- The company has received registration for fluindapyr herbicide containing Isoflex active in Great Britain, with sales anticipated to begin in August.
- FMC Corp (FMC) is implementing a new direct sales route in Brazil, targeting large corn and soybean growers, which is expected to show results starting in the third quarter.
- FMC Corp (FMC) faced a 3% decline in pricing during the second quarter, partly due to pricing adjustments with diamide partners.
- The company is experiencing ongoing challenges in India, including a fragmented distribution channel and intense generic competition.
- FMC Corp (FMC) has decided to divest its commercial business in India due to limited EBITDA generation and substantial working capital requirements.
- The company anticipates a mid-single-digit price decline and flat to low single-digit FX headwinds for the full year, impacting revenue.
- Free cash flow for the second quarter was significantly lower than the prior year, primarily due to the absence of a significant inventory reduction seen previously.
Good morning, and welcome to the second quarter 2025 earnings call for FMC Corporation. This event is being recorded. (Operator Instructions)
I would like to turn the conference over to Mr. Curt Brooks, Director of Investor Relations for FMC Corporation. Please go ahead.
Good morning, everyone, and welcome to FMC Corporation's second quarter earnings call. Joining me are Pierre Brondeau, Chairman and Chief Executive Officer; Andrew Sandifer, Executive Vice President and Chief Financial Officer; and Ronaldo Pereira, President. Today, Pierre will review our second quarter performance and provide outlooks for the third quarter and fourth quarter. Andrew will provide an overview of select financial results. After our prepared remarks, we will take questions.
Our earnings release and today's slide presentation are available on our website, and the prepared remarks from today's discussion will be made available after the call.
Let me remind you that today's presentation and discussion
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

